FENU, SANDRO
 Distribuzione geografica
Continente #
EU - Europa 124.978
NA - Nord America 8.168
AS - Asia 3.266
SA - Sud America 550
AF - Africa 53
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 5
Totale 137.029
Nazione #
IT - Italia 122.676
US - Stati Uniti d'America 8.052
SG - Singapore 1.316
CN - Cina 1.165
UA - Ucraina 704
BR - Brasile 451
SE - Svezia 405
DE - Germania 381
VN - Vietnam 272
FI - Finlandia 254
GB - Regno Unito 212
FR - Francia 176
HK - Hong Kong 123
KR - Corea 90
IN - India 73
CA - Canada 69
RU - Federazione Russa 51
BD - Bangladesh 35
AR - Argentina 31
EC - Ecuador 24
IQ - Iraq 23
TR - Turchia 23
JP - Giappone 22
MX - Messico 20
BE - Belgio 17
ES - Italia 17
PK - Pakistan 17
PL - Polonia 16
CO - Colombia 14
ZA - Sudafrica 14
JM - Giamaica 12
NL - Olanda 12
ID - Indonesia 11
IR - Iran 10
UZ - Uzbekistan 10
IE - Irlanda 9
MA - Marocco 9
PH - Filippine 9
EU - Europa 8
VE - Venezuela 8
SA - Arabia Saudita 7
AZ - Azerbaigian 6
DZ - Algeria 6
IL - Israele 6
KE - Kenya 6
UY - Uruguay 6
AL - Albania 5
CZ - Repubblica Ceca 5
EG - Egitto 5
JO - Giordania 5
RO - Romania 5
TN - Tunisia 5
AU - Australia 4
BO - Bolivia 4
CL - Cile 4
CR - Costa Rica 4
OM - Oman 4
PY - Paraguay 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
BG - Bulgaria 3
BN - Brunei Darussalam 3
CH - Svizzera 3
LT - Lituania 3
MD - Moldavia 3
MY - Malesia 3
NP - Nepal 3
PE - Perù 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
BB - Barbados 2
BY - Bielorussia 2
CY - Cipro 2
GR - Grecia 2
GT - Guatemala 2
HU - Ungheria 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
MN - Mongolia 2
NO - Norvegia 2
PA - Panama 2
PT - Portogallo 2
RS - Serbia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
AO - Angola 1
BW - Botswana 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GY - Guiana 1
HR - Croazia 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
Totale 137.022
Città #
Cagliari 120.369
Uta 1.951
Fairfield 765
Woodbridge 711
Singapore 663
Ashburn 637
Chandler 561
San Jose 473
Houston 438
Ann Arbor 406
Jacksonville 380
Boardman 374
Dallas 362
Wilmington 353
Seattle 309
Nyköping 272
Cambridge 248
Beijing 188
Dearborn 157
Helsinki 146
Los Angeles 122
Nanjing 117
Santa Clara 108
Hong Kong 107
Lauterbourg 101
Ho Chi Minh City 96
Hefei 94
Boston 89
Seoul 88
The Dalles 82
Shanghai 79
Buffalo 69
Hanoi 63
New York 59
Milan 51
Council Bluffs 47
Guangzhou 45
San Diego 41
São Paulo 39
Shenyang 38
Toronto 37
Nanchang 32
Hebei 30
Redwood City 30
Changsha 27
Jiaxing 27
Tianjin 27
Norwalk 26
Verona 25
Orem 19
Frankfurt am Main 18
Chicago 17
Mountain View 17
Brussels 16
London 15
Washington 15
Auburn Hills 14
Munich 14
Redondo Beach 14
Tokyo 14
Chennai 13
Kunming 13
Montreal 13
Orange 13
Augusta 12
Brasília 12
Upgant-schott 12
Zhengzhou 12
Hangzhou 11
Ningbo 11
Atlanta 10
Jinan 10
Rio de Janeiro 10
Columbus 9
Curitiba 9
Da Nang 9
Kingston 9
Mumbai 9
San Mateo 9
Tashkent 9
Brooklyn 8
Campinas 8
Guarulhos 8
Haiphong 8
Istanbul 8
Quito 8
Saint Petersburg 8
San Francisco 8
Ardabil 7
Belo Horizonte 7
Biên Hòa 7
Juiz de Fora 7
Naples 7
New Delhi 7
Rome 7
Salvador 7
Sassari 7
Assèmini 6
Baghdad 6
Casalecchio di Reno 6
Totale 132.092
Nome #
Acquisition and expression of conditioned taste aversion differentially affects extracellular signal regulated kinase and glutamate receptor phosphorylation in rat prefrontal cortex and nucleus accumbens 4.608
null 4.110
Role of nucleus accumbens μ opioid receptors in the effects of morphine on ERK1/2 phosphorylation 4.057
Caffeine and the brain: an overview 3.737
Pharmacological characterization of 50-kHz ultrasonic vocalizations in rats: comparison of the effects of different psychoactive drugs and relevance in drug-induced reward 3.659
Immunomodulatory drugs alleviate l-dopa-induced dyskinesia in a rat model of Parkinson's disease 3.464
Strain dependence of adolescent Cannabis influence on heroin reward and mesolimbic dopamine transmission in adult Lewis and Fischer 344 rats 3.380
Behavioural pharmacology of caffeine 3.213
Evaluation of rewarding properties of pramipexole in a rat model of Parkinson’s disease: role of genetic background 3.094
Neuroinflammation in L-DOPA-induced dyskinesia: beyond the immune function 2.945
Behavioral Pharmacology of Caffeine 2.817
Conditioned saccharin avoidance induced by infusion of amphetamine in the Nucleus Accumbens shell and morphine in the Ventral Tegmental Area: behavioral and biochemical study 2.723
L dopa chronic treatment increases reactive microglia and tnf- alpha production in the 6-ohda lesioned striatum 2.708
In vivo dopamine agonist properties of rotigotine: Role of D1 and D2 receptors 2.678
Conditioned saccharin avoidance induced by infusion of amphetamine in the Nucleus Accumbens shell and morphine in the Ventral Tegmental Area: a behavioral and biochemical study 2.559
Disease modifying treatment with PPAR-gamma agonist rosiglitazone in a progressive mouse model of Parkinson's disease 2.495
Adolescent Cannabis exposure differentially affects heroin reinforcement and accumbens dopamine transmission in Lewis and Fischer344 rats 2.470
Possibile ruolo dei recettori 5-HT6 nelle dipendenze 2.260
null 2.160
null 2.148
Conditioned Saccharine Avoidance induced by intra-Accumbens shell amphetamine and intra-VTA morphine 2.138
Conditioned Saccharine Avoidance induced by infusion of amphetamine in the Nucleus Accumbens shell and morphine in the Ventral Tegmental Area 2.124
Behavioral and neurochemical pharmacology of 5-HT6 receptors related to reward and reinforcement 2.098
Influence of strain and age on voluntarily ethanol intake and on GAD-67 expression in the central amygdala 2.087
Morphine-conditioned single-trial place preference: role of nucleus accumbens shell dopamine receptors in acquisition, but not expression 2.039
Possibile ruolo dei recettori 5-HT6 nelle dipendenze - Possible role of 5-HT6 receptors in addictions 2.016
null 1.797
Pharmacological therapy of Parkinson's disease: current options and new avenues 1.784
Effect of adenosine A1 and A2A antagonists on 3,4 methylenedioxymethamphetamine (MDMA)-induced neuroinflammation and dopamine neuron toxicity in mouse brain 1.754
Nicotine-conditioned single-trial place preference: selective role of nucleus accumbens shell dopamine D1 receptors in acquisition 1.741
Caffeine potentiation of 3,4-methylenedioxymethamphetamine (MDMA) toxicity: role of age 1.639
Reinforcing, rewarding and dopamine-stimulant properties of the 5-HT6 receptor agonist ST1936: the first member of a new class of psychostimulant? 1.597
null 1.580
REINFORCING, REWARDING AND DOPAMINE-STIMULANT PROPERTIES OF THE 5-HT6 RECEPTOR AGONIST ST1936: THE FIST MEMBER OF A NEW CLASS OF PSYCHOSTIMULANTS? 1.573
Controversie: Priming dopaminergico nel Parkinson. Il "priming" come modello sperimentale delle discinesie indotte da terapie dopaminergiche sostitutive nella Malattia di Parkinson 1.529
Blockade of globus pallidus adenosine A2A receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D1 or D2 dopamine receptor agonists 1.298
Effects of QO-IIR, a new COMT inhibitor, in experimental animal models of parkinson’s disease: behavioural, neurochemical and immunoistochemical study 1.269
Caffeine potentiates 3,4 methylenedioxymethamphetamine (MDMA, ecstasy)-induced-glial activation: role of age and adenosine A1 and A2A receptors 1.104
Differential involvement of dopamine D1 receptors in morphine- and lithium- conditioned saccharin avoidance 1.093
Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson's disease 1.027
Role of Adenosine A1 and A2A receptors on 3,4-methylendioxymeth-amphetamine (MDMA, Ecstasy)-induced neurotoxicity, astroglia and microglia reactivity in mouse striatum and substantia nigra 1.009
Differential effect of MK 801 and scopolamine on c-fos expression induced by L-dopa in the striatum of 6-hydroxydopamine lesioned rats 968
Selective modifications in GAD67 mRNA levels in striatonigral and striatopallidal pathways correlate to dopamine agonist priming in 6-hydroxydopamine-lesioned rats 929
A role for dopamine D1 receptors of the nucleus accumbens shell in conditioned taste aversion learning 919
Alterations in GAD67, dynorphin and enkephalin mRNA in striatal output neurons following priming in the 6-OHDA model of Parkinson’s disease 838
Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous L-DOPA delivery in the 6-OHDA model of Parkinson's disease 825
Blockade of muscarinic receptors potentiates D1 dependent turning behavior and c-fos expression in 6-hydroxydopamine-lesioned rats but does not influence D2 mediated responses 817
null 801
Modulation of dopamine d1-mediated turning behavior and striatal c-fos expression by the substantia nigra 796
Effect of MK 801 on priming of D-1-dependent contralateral turning and its relationship to c-fos expression in the rat caudate-putamen 770
Conditioned saccharin avoidance and sensitization to drugs of abuse 768
Accumbens shell dopamine and stimulus-reward learning 765
“Priming” to dopamine agonist-induced contralateral turning as model of non associative sensitization to the expression of the post-synaptic dopamine message 762
Effetto del blocco dei recettori oppioidi delta sul turning controlaterale indotto dagli agonisti dopaminergici in ratti lesionati con la 6-idrossidopamina 720
Influence of Age and Genetic Background on Ethanol Intake and Behavioral Response Following Ethanol Consumption and During Abstinence in a Model of Alcohol Abuse 700
Dopamine and drug addiction: the nucleus accumbens shell connection 696
Behavioural expression of D-1 receptor supersensitivity depends on previous stimulation of D-2 receptors 691
Conditioned saccharin avoidance and sensitization to drugs of abuse 671
Blockade of pallidal adenosine A2A receptors potentiates contralateral rotational behavior induced by L-DOPA and dopaminergic agonists in hemiparkinsonian rats 656
Changes in GAD67 and peptides mRNA levels in specific populations of striatal efferent neurons following priming with dopamine agonists in 6-OHDA lesioned rats 646
Adenosine A2 Receptors interact negatively with dopamine D1 and D2 receptors in unilaterally 6-hydroxydopamine-lesioned rats 645
Different involvement of Dopamine D1 receptor in morphine and lithium conditioned saccharin avoidance 635
Time and dose dependence of the 'priming' of the expression of dopamine receptor supersensitivity. 633
Positive and negative interactions in the behavioural expression of D1 and D2 receptor stimulation in a model of parkinsonism: role of priming 633
Alterazioni nei livelli striatali di RNAm della GAD67, dinorfina e enkefalina, in seguito a priming con agonisti dopaminergici nel modello di morbo di parkinson della 6-ohda 630
 and  opiate receptors mediate specific behavioral syndromes from the Substantia Nigra. 628
Blockade of n-methyl-d-aspartate receptors potentiates dopaminergic responses in the 6-ohda model of parkinson: differential role of D1 and D2 receptors 621
Differential effect of priming with dopamine agonists on mrna for GAD-67, dynorphin and enkephalin in 6-OHDA lesioned rats 615
Effect of delta opioid receptors blockade on turning behavior induced by dopamine agonists in unilaterally 6-hydroxydopamine lesioned rats 611
null 594
Substantia nigra as a site of origin of dopamine-dependent motor syndromes induced by stimulation of mu and delta opioid receptors. 593
null 580
‘Priming’ phenomena in the expression of D1 and D2 receptor supersensitivity 574
Different involvement of dopamine D1 receptor in morphine- and lithium-induced conditioned saccharin avoidance 564
Opposite effects of nmda receptor blockade on dopaminergic d1-mediated and d2-mediated behavior in the 6-hydroxydopamine model of turning - relationship with c-fos expression 558
Differential role of dopamine in drug- and lithium conditioned saccharin avoidance 555
CONDITIONED TASTE AVERSION ELICITED ERK ACTIVATION AND CHANGES OF DENDRITIC SPINES DENSITY: AN IMMUNOHISTOCHEMICAL, GOLGI-COX AND ELECTRON MICROSCOPY STUDY 545
Blockade of n-methyl-d-aspartate receptors potentiates dopaminergic responses in the 6-ohda model of parkinson: differential role of D1 and D2 receptors 539
Opposite effects of NMDA receptor blockade on dopaminergic D1 and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression 528
Modulation of turning behavior induced by dopamine D1 agonists in 6-hydroxydopamine lesioned rats by intranigral infusion of glutamate antagonists. 523
null 515
Modulation of Delta(9)-THC-induced increase of cortical and hippocampal acetylcholine release by micro opioid and D(1) dopamine receptors 514
null 504
The influence of priming on the behavioral expression of dopamine receptor supersensitivity in basal ganglia 481
null 479
Priming of the behavioral expression of dopamine-receptor supersensitivity in the basal ganglia: pharmacological and biochemical studies 451
Nicotine-conditioned single–trial place preference: selective role of nucleus accumbens shell dopamine D1 receptors in acquisition 447
Differential role of dopamine in drug- and lithium-conditioned saccharin avoidance 435
Priming of the behavioral of dopamine-receptor supersensitivity in the basal ganglia: pharmacological and biochemical studies 434
Blockade of NMDA receptors differentially affects D1 and D2 mediated turning behavior in the 6-hydroxydopamine model of Parkinson 430
null 425
Cross-sensitization between the motor activating effects of bromocriptine and caffeine: role of adenosine A2A receptors 419
Dissociation of dopamine D1-induced turning behaviour and D1-induced increases in striatal acetylcholine release in 6-OHDA lesioned rats 407
Ruolo dell’acetilcolina striatale sul turning indotto dagli agonisti dopaminergici D1 in un modello sperimentale di morbo di parkinson: studio combinato microdialisi/comportamento. 398
Motor stimulant effects of caffeine in 6-hydroxydopamine lesioned rats are dependent on previous stimulation of dopamine receptors: a different role of D1 and D2 receptors 397
Facilitation of conditioned taste aversion learning by systemic amphetamine: role of nucleus accumbens shell dopamine D1 receptors 386
Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats 380
Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease 367
Drug addiction as a disorder of associative learning. Role of nucleus accumbens shell/extended amygdala dopamine 352
Involvement of globus pallidus in the antiparkinsonian effects of adenosine A2A receptor antagonists 350
Totale 130.694
Categoria #
all - tutte 178.509
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 178.509


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.017 0 0 0 0 0 0 0 0 0 0 0 1.017
2021/20225.302 677 488 276 417 493 326 251 265 507 566 547 489
2022/20237.785 624 961 1.037 665 565 767 427 687 556 582 632 282
2023/202410.460 502 1.523 597 805 999 1.433 1.135 834 369 660 791 812
2024/202511.108 1.242 1.904 2.184 1.535 976 1.042 1.115 122 262 265 202 259
2025/20265.541 304 235 707 486 341 351 1.405 321 363 585 358 85
Totale 137.255